Category: M&A, Partnerships
Thermo Fisher Scientific Collaborates to Introduce Fully Automated Cell Line Automation Platform
Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics BURLINGTON, Ontario – (February 6, 2023) — Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture... Read more
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and development, and clinical trials leveraging pharmacoproteomics With Bruker investments, Biognosys plans to open advanced US proteomics CRO facility for proteomics biomarker and drug... Read more
Promoting Development and Commercialization of Innovative Technologies Through Collaboration Between Industry and AcademiaComprehensive Collaborative Agreement Signed with Kyoto University Aiming at Creating New Business Activities
Promoting Development and Commercialization of Innovative Technologies Through Collaboration Between Industry and AcademiaComprehensive Collaborative Agreement Signed with Kyoto University Aiming at Creating New Business Activities Read more
Hamilton and BioFluidiX head into the future together
Hamilton acquires the microdosing company BioFluidiX. The companies have an established partnership that will continue to grow under this agreement. November 21, 2022 – Hamilton announced today that it is expanding its microfluidics product range with the acquisition of the microdosing company, BioFluidiX. BioFluidiX’s patented microdosing processes enable precise dosing in the nano and picoliter... Read more
Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
Delivers Simultaneous Multi-Region Neural Imaging of Free-Behaving Animals BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off... Read more
Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation
Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation WASHINGTON, Nov. 10, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacons is a... Read more